Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Der Internist

Showing results (291-300 of 7,729) with videos related to

Pageof 773
Sort By:
Der Internist|May 13, 2015
[Hyponatremia and tolvaptan : what is the situation 5 years after approval?]J Hensen
Der Internist|March 1, 1977
[Stages and limits in the diagnosis of pulmonary diseases]G Siemon, R Thoma
Der Internist|March 1, 1977
[Stages and limits in the diagnosis of kidney diseases and hypertension]H G Sieberth
Der Internist|March 1, 1977
[Stages and limits in the diagnosis of metabolic disorders and endocrine diseases]M Neubauer, K Schöffling
Der Internist|April 26, 2020
[Thyroid hormone therapy in old age]K A Iwen, G Brabant
Der Internist|May 13, 2020
[Modified-release hydrocortisone for glucocorticoid deficiency]H Nowotny, N Reisch
Der Internist|May 13, 2020
[Lipidology update : Evidence-based treatment of dyslipidemia]K G Parhofer
Der Internist|May 6, 2020
[Patient safety: current problems and challenges]M Schrappe, H Müller, R Hecker
Der Internist|December 24, 1997
[Amiodaron improves prognosis in high risk patients]
Der Internist|October 1, 1996
[ACE-inhibitors indicated even in non-diabetic nephropathy]
Pageof 773

Showing results (291-300 of 7,729) with videos related to

Sort By:
Pageof 773
Der Internist|May 13, 2015
[Hyponatremia and tolvaptan : what is the situation 5 years after approval?]J Hensen
Der Internist|March 1, 1977
[Stages and limits in the diagnosis of pulmonary diseases]G Siemon, R Thoma
Der Internist|March 1, 1977
[Stages and limits in the diagnosis of kidney diseases and hypertension]H G Sieberth
Der Internist|March 1, 1977
[Stages and limits in the diagnosis of metabolic disorders and endocrine diseases]M Neubauer, K Schöffling
Der Internist|April 26, 2020
[Thyroid hormone therapy in old age]K A Iwen, G Brabant
Der Internist|May 13, 2020
[Modified-release hydrocortisone for glucocorticoid deficiency]H Nowotny, N Reisch
Der Internist|May 13, 2020
[Lipidology update : Evidence-based treatment of dyslipidemia]K G Parhofer
Der Internist|May 6, 2020
[Patient safety: current problems and challenges]M Schrappe, H Müller, R Hecker
Der Internist|December 24, 1997
[Amiodaron improves prognosis in high risk patients]
Der Internist|October 1, 1996
[ACE-inhibitors indicated even in non-diabetic nephropathy]
Pageof 773